SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-299532
Filing Date
2023-12-20
Accepted
2023-12-20 10:39:49
Documents
8
Period of Report
2023-12-20

Document Format Files

Seq Description Document Type Size
1 6-K d637412d6k.htm 6-K 11650
2 EX-99.1 d637412dex991.htm EX-99.1 23046
3 EX-99.2 d637412dex992.htm EX-99.2 22997
4 EX-99.3 d637412dex993.htm EX-99.3 27473
5 EX-99.4 d637412dex994.htm EX-99.4 11808
6 EX-99.5 d637412dex995.htm EX-99.5 25088
7 GRAPHIC g637412dsp7.jpg GRAPHIC 2511
8 GRAPHIC g637412g1219045807411.jpg GRAPHIC 2601
  Complete submission text file 0001193125-23-299532.txt   130607
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 231500217
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)